EquityFlow
›
Companies
› Helex
Helex
Biotech
Terapie geniche mirate per malattie renali genetiche con piattaforma di drug design 3D.
Funding history
Date
Round
Amount
Oct 2025
Seed
Helex raised $3.5M in a seed led by pi Ventures for pre-clinical development of its drug against ADPKD.
$3.5M
Investors
Bluehill.VC
SOSV
pi Ventures
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →